Reaction

Placental Hypertrophy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 40 reports · 1 co-occurring drugs

As of the last recalculation, Placental Hypertrophy appears in 40 FAERS reports alongside 1 co-occurring drug terms. The strongest observed disproportionality signal is BUPRENORPHINE (PRR 303.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Buprenorphine	23	303.0	303.0

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.